6. Jung Symposium „Ausgezeichnete Humanmedizin 2026“

Under the theme “Excellence in Human Medicine 2026”, the Jung Foundation invites you to experience groundbreaking research findings with direct benefits for patients via livestream on 20 May 2026.

How can artificial intelligence support surgical decision-making in cancer cases? Which molecular mechanisms help us to better understand and diagnose rare diseases?

And what does it mean for treatment when the nervous system “learns” pain?

These questions are at the heart of the 6th Jung Symposium “Excellent Human Medicine 2026” organised by the Jung Foundation for Science and Research, which will take place on 20 May 2026 in Hamburg and via livestream. The event will be conducted in English, and attendance is free of charge.

The event focuses on current research with direct benefits for patients: Dr Fiona Kolbinger, an up-and-coming young scientist, will speak about how AI can help plan surgical procedures more safely.

Professor Taroh Kinoshita, a leading authority in GPI biochemistry, will give a lecture on GPI anchoring and its role in rare diseases. And Professor Rohini Kuner, one of the leading researchers in pain science, will explore new approaches to the treatment of chronic pain. Following the presentations, there will be time for questions and discussion.

The symposium will take place on 20 May 2026 from 4.00 pm as a hybrid event – livestreamed worldwide and also in person at the University Medical Centre Hamburg-Eppendorf (UKE), in the Ian K. Karan Lecture Theatre.

Those interested are asked to register in advance at https://jung-stiftung.de/en/symposium-2026/.

The Jung Foundation invites all interested parties to attend; the announcement and further promotion of the 2026 Jung Symposium are expressly encouraged.